Keyphrases
Thrombosis
100%
Acute Lymphoblastic Leukemia
100%
Thromboembolism
100%
Overall Survival
45%
Event-free Survival
45%
Ultra-high Risk
27%
High Risk
9%
Cox Regression Model
9%
Canada
9%
Low Risk
9%
Tumor Thromboembolism
9%
Cancer Development
9%
Median Time
9%
Clinical High Risk
9%
Leukemia
9%
Multivariable Cox Regression
9%
Young People
9%
Exposure Parameters
9%
Low-risk Patients
9%
Population-based Retrospective Cohort Study
9%
Conflict Data
9%
De Novo Acute Lymphoblastic Leukaemia
9%
Medical Intervention
9%
Leukemia Diagnosis
9%
Second Malignancy
9%
Precursor B-cell Acute Lymphoblastic Leukemia
9%
High-risk Acute Leukemia
9%
Medicine and Dentistry
Thromboembolism
100%
Thrombosis
100%
Acute Lymphoblastic Leukemia
100%
Overall Survival
41%
Event Free Survival
41%
Malignant Neoplasm
16%
Proportional Hazards Model
8%
Retrospective Cohort Study
8%
Leukemia
8%
Precursor
8%
Acute B-Cell Lymphoblastic Leukemia
8%
Second Cancer
8%
Medical Intervention
8%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Event Free Survival
100%
Cohort Study
20%
Precursor
20%
B Cell
20%
Immunology and Microbiology
Overall Survival
100%
Event Free Survival
100%
B Cell
20%
Precursor
20%